多囊性卵巣症候群における内皮細胞マーカーの調節不全
Preeti Borde1, Sara Anjum Niinuma1, Haniya Habib1
1Royal College of Surgeons in Ireland Bahrain, Adliya, 15503, Kingdom of Bahrain.
Scientific reports
|February 16, 2026
まとめ
多囊性卵巣症候群 (PCOS) は,肥満とは関係なく,内皮細胞機能不全に関連しています. PCOSの肥満女性は,内皮活性化と凝固の明確なタンパク質マーカーを示しており,心臓血管疾患のリスクが高いことを示唆しています.
科学分野:
- エンドクリノロジー エンドクリノロジー
- 心血管科学 心血管科学
- プロテオミクス プロテオミクスは,プロテオミクスの
背景:
- 内皮細胞機能不全は,多囊性卵巣症候群 (PCOS) で観察されています.
- この機能不全が肥満に二次的なのか,またはPCOSの病理生理学に内在しているかは不明である.
- この研究では,PCOSに関連する内皮機能障害マーカーを調査し,肥満をコントロールしています.
研究 の 目的:
- 内皮細胞機能不全のタンパク質マーカーがボディマス指数 (BMI) にマッチした肥満の女性とPCOSの女性との間で異なっているかどうかを判断する.
- 肥満とは独立して,内皮機能不全におけるPCOSの病理生理学の役割を調査する.
主な方法:
- PCOSとコントロールのバイオバンクを利用して,PCOSの女性92人とコントロールの女性19人を募集しました.
- 肥満 (BMI ≥30 kg/m2) に適合した被験者
- 採用されたSlow Off-rate Modified Aptamer (SOMA) - 内皮機能不全マーカーを測定するためにプロテオミクスをスキャンする.
主要な成果:
- 細胞間粘着分子-1 (ICAM1),組織プラズミノゲン活性化剤 (tPA),プラズミノゲン活性化剤阻害剤-1 (PAI-1),およびD-ダイマーが,対照群と比較して,PCOSの女性において,著しく上昇した.
- これらのマーカーは,インスリン抵抗性 (IR) やハイパーアンドロゲネミアと相関していません.
- BMI,C反応性タンパク質 (CRP),および性ホルモン結合タンパク質 (SHBG) は差異はなかったが,IRとテストステロンはPCOSで高かった.
結論:
- 内皮機能不全は,PCOSの病理生理学の固有の特徴であり,肥満のみに起因するものではありません.
- 内皮活性化 (ICAM1) と凝固/繊維分解 (tPA,PAI-1,D-ダイマー) のマーカーの上昇は,PCOSで心血管疾患のリスクと直接的な関連性を示しています.
関連する概念動画
Oogenesis
70.3K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.3K
Hormonal Regulation of the Menstrual Cycle
1.7K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.7K
Hormonal Control of the Ovarian Cycle
7.1K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.1K
Coronary Artery Disease II: Pathophysiology
571
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
571
Disorders of the Female Reproductive System
4.6K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.6K


